Üriner Sistem Taş Hastalığının Epidemiyolojisi ve Etiyopatogenezi

Campbell-Walsh-Wein Urology. 12th ed. Elsevier; 2021. Chapter: Nephrolithiasis.

Scales CD Jr, et al. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160-5.

Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2-3):e86-96.

Zhao Y, et al. Epidemiology of kidney stones in China: an analysis of data from the China National Health and Nutrition Survey. BJU Int. 2019;124(4):649-655.

Müller R, et al. The pathophysiology of kidney stones: from molecular mechanisms to clinical management. Nephrol Dial Transplant. 2010;25(11):3456-3464.

Taylor EN, et al. Pathophysiology of kidney stone formation. J Urol. 2011;185(5):1373-1377.

Nilsen A, et al. Calcium stone disease: pathogenesis and management. Nat Rev Urol. 2019;16(1):10-20.

Mikami T, et al. Pathophysiology of calcium oxalate kidney stones. Nephrol Dial Transplant. 2003;18(7):1453-1459.

Sisti JM, et al. Cystine stones: Current clinical approach. Urol Clin North Am. 2018;45(1):35-44.

Zhang L, et al. Infection stones: microbiological and clinical perspectives. Int J Urol. 2014;21(10):941-946.

Muehling T, et al. Drug-induced nephrolithiasis. Eur Urol. 2009;55(3):500-507.

Zhao Z, et al. Medication-induced urolithiasis. J Urol. 2014;191(4):950-955.

Praga M, et al. Genetic aspects of nephrolithiasis. J Am Soc Nephrol. 2000;11(9):1863-1873.

Mühlberger T, et al. Familial nephrolithiasis: genetic insights and clinical implications. Nat Rev Nephrol. 2015;11(5):316-324.

Assimos DG, et al. Kidney stone disease: medical management. Urology. 2012;79(2):390-395.

Wang J, et al. Management of renal stones: a review of current approaches. Nat Rev Urol. 2020;17(6):339-349.

Lohiya G, et al. Novel therapies in urolithiasis: from molecular approaches to clinical management. World J Urol. 2021;39(2):355-364.